Quantitative Susceptibility Mapping Identifies Inflammation in a Subset of Chronic Multiple Sclerosis Lesions

Document Type


Publication Date


Publication Title



Chronic active multiple sclerosis lesions, characterized by a rim of immune cells, have been linked to greater tissue damage. Kaunzner et al. combine quantitative susceptibility mapping (QSM, a novel MRI sequence) with PK11195 PET and immunohistochemistry, and report that a bright QSM rim within chronic lesions correlates with persistent inflammation.Chronic active multiple sclerosis lesions, characterized by a hyperintense rim of iron-enriched, activated microglia and macrophages, have been linked to greater tissue damage. Post-mortem studies have determined that chronic active lesions are primarily related to the later stages of multiple sclerosis; however, the occurrence of these lesions, and their relationship to earlier disease stages may be greatly underestimated. Detection of chronic active lesions across the patient spectrum of multiple sclerosis requires a validated imaging tool to accurately identify lesions with persistent inflammation. Quantitative susceptibility mapping provides efficient in vivo quantification of susceptibility changes related to iron deposition and the potential to identify lesions harbouring iron-laden inflammatory cells. The PET tracer C-11-PK11195 targets the translocator protein expressed by activated microglia and infiltrating macrophages. Accordingly, this study aimed to validate that lesions with a hyperintense rim on quantitative susceptibility mapping from both relapsing and progressive patients demonstrate a higher level of innate immune activation as measured on C-11-PK11195 PET. Thirty patients were enrolled in this study, 24 patients had relapsing remitting multiple sclerosis, six had progressive multiple sclerosis, and all patients had concomitant MRI with a gradient echo sequence and PET with C-11-PK11195. A total of 406 chronic lesions were detected, and 43 chronic lesions with a hyperintense rim on quantitative susceptibility mapping were identified as rim+ lesions. Susceptibility (relative to CSF) was higher in rim+ (2.42 17.45 ppb) compared to rim lesions (14.6 19.3 ppb, P < 0.0001). Among rim+ lesions, susceptibility within the rim (20.04 14.28 ppb) was significantly higher compared to the core (5.49 14.44 ppb, P < 0.0001), consistent with the presence of iron. In a mixed-effects model, C-11-PK11195 uptake, representing activated microglia/macrophages, was higher in rim+ lesions compared to rim lesions (P = 0.015). Validating our in vivo imaging results, multiple sclerosis brain slabs were imaged with quantitative susceptibility mapping and processed for immunohistochemistry. These results showed a positive translocator protein signal throughout the expansive hyperintense border of rim+ lesions, which co-localized with iron containing CD68+ microglia and macrophages. In conclusion, this study provides evidence that suggests that a hyperintense rim on quantitative susceptibility measure within a chronic lesion is a correlate for persistent inflammatory activity and that these lesions can be identified in the relapsing patients. Utilizing quantitative susceptibility measure to differentiate chronic multiple sclerosis lesion subtypes, especially chronic active lesions, would provide a method to assess the impact of these lesions on disease progression.